Gliflozins in the Management of Cardiovascular Disease

被引：171
作者：
Braunwald, Eugene [1 ,2 ,3 ]
机构：
[1] Brigham & Womens Hosp, Div Cardiovasc Med, TIMI Study Grp, Hale Bldg Transformat Med,Suite 7022,60 Fenwood Rd, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Div Cardiovasc Med, TIMI Study Grp, Boston, MA USA
[3] Harvard Med Sch, Dept Med, Boston, MA USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2022年 / 386卷 / 21期
关键词：
COTRANSPORTER; 2; INHIBITORS; REDUCED EJECTION FRACTION; HEART-FAILURE; SGLT2; DIABETES-MELLITUS; KIDNEY-DISEASE; EMPAGLIFLOZIN; DEATH; NA+; DAPAGLIFLOZIN;
D O I：
10.1056/NEJMra2115011
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Gliflozins in Cardiac and Renal DiseaseGliflozins - sodium-glucose cotransporter 2 inhibitors - lower blood glucose and glycated hemoglobin in patients with type 2 diabetes without causing hypoglycemia. The agents also improve cardiac function in patients who have heart failure with or without type 2 diabetes and improve renal function, with few adverse effects.
引用
收藏
页码：2024 / 2034
页数：11
相关论文
共 87 条
[1]   T-1095, a renal Na+-glucose transporter inhibitor, improves hyperglycemia in streptozotocin-induced diabetic rats [J].
Adachi, T ;
Yasuda, K ;
Okamoto, Y ;
Shihara, N ;
Oku, A ;
Ueta, K ;
Kitamura, K ;
Saito, A ;
Iwakura, T ;
Yamada, Y ;
Yano, H ;
Seino, Y ;
Tsuda, K .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2000, 49 (08) :990-995
[2]   10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2022 [J].
American Diabetes Association Professional Practice Committee .
DIABETES CARE, 2022, 45 :S144-S174
[3]   Empagliflozin in Heart Failure with a Preserved Ejection Fraction [J].
Anker, Stefan D. ;
Butler, Javed ;
Filippatos, Gerasimos ;
Ferreira, Joao P. ;
Bocchi, Edimar ;
Boehm, Michael ;
Brunner-La Rocca, Hans-Peter ;
Choi, Dong-Ju ;
Chopra, Vijay ;
Chuquiure-Valenzuela, Eduardo ;
Giannetti, Nadia ;
Gomez-Mesa, Juan Esteban ;
Janssens, Stefan ;
Januzzi, James L. ;
Gonzalez-Juanatey, Jose R. ;
Merkely, Bela ;
Nicholls, Stephen J. ;
Perrone, Sergio V. ;
Pina, Ileana L. ;
Ponikowski, Piotr ;
Senni, Michele ;
Sim, David ;
Spinar, Jindrich ;
Squire, Iain ;
Taddei, Stefano ;
Tsutsui, Hiroyuki ;
Verma, Subodh ;
Vinereanu, Dragos ;
Zhang, Jian ;
Carson, Peter ;
Lam, Carolyn Su Ping ;
Marx, Nikolaus ;
Zeller, Cordula ;
Sattar, Naveed ;
Jamal, Waheed ;
Schnaidt, Sven ;
Schnee, Janet M. ;
Brueckmann, Martina ;
Pocock, Stuart J. ;
Zannad, Faiez ;
Packer, Milton .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (16) :1451-1461
[4]  
[Anonymous], 2022, Food and Drug Administration
[5]   Effects of Newer Antidiabetic Drugs on Endothelial Function and Arterial Stiffness: A Systematic Review and Meta-Analysis [J].
Batzias, Konstantinos ;
Antonopoulos, Alexios S. ;
Oikonomou, Evangelos ;
Siasos, Gerasimos ;
Bletsa, Evanthia ;
Stampouloglou, Panagiota K. ;
Mistakidi, Chara-Vasiliki ;
Noutsou, Marina ;
Katsiki, Niki ;
Karopoulos, Periklis ;
Charalambous, Georgios ;
Thanopoulou, Anastasia ;
Tentolouris, Nicholas ;
Tousoulis, Dimitris .
JOURNAL OF DIABETES RESEARCH, 2018, 2018
[6]   Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure [J].
Bhatt, Deepak L. ;
Szarek, Michael ;
Steg, P. Gabriel ;
Cannon, Christopher P. ;
Leiter, Lawrence A. ;
McGuire, Darren K. ;
Lewis, Julia B. ;
Riddle, Matthew C. ;
Voors, Adriaan A. ;
Metra, Marco ;
Lund, Lars H. ;
Komajda, Michel ;
Testani, Jeffrey M. ;
Wilcox, Christopher S. ;
Ponikowski, Piotr ;
Lopes, Renato D. ;
Verma, Subodh ;
Lapuerta, Pablo ;
Pitt, Bertram .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (02) :117-128
[7]   Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease [J].
Bhatt, Deepak L. ;
Szarek, Michael ;
Pitt, Bertram ;
Cannon, Christopher P. ;
Leiter, Lawrence A. ;
McGuire, Darren K. ;
Lewis, Julia B. ;
Riddle, Matthew C. ;
Inzucchi, Silvio E. ;
Kosiborod, Mikhail N. ;
Cherney, David Z. I. ;
Dwyer, Jamie P. ;
Scirica, Benjamin M. ;
Bailey, Clifford J. ;
Diaz, Rafael ;
Ray, Kausik K. ;
Udell, Jacob A. ;
Lopes, Renato D. ;
Lapuerta, Pablo ;
Steg, P. Gabriel .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (02) :129-139
[8]   Diabetes, heart failure, and renal dysfunction: The vicious circles [J].
Braunwald, Eugene .
PROGRESS IN CARDIOVASCULAR DISEASES, 2019, 62 (04) :298-302
[9]   SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications [J].
Brown, Emily ;
Heerspink, Hiddo J. L. ;
Cuthbertson, Daniel J. ;
Wilding, John P. H. .
LANCET, 2021, 398 (10296) :262-276
[10]   Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction [J].
Butler, Javed ;
Packer, Milton ;
Filippatos, Gerasimos ;
Ferreira, Joao Pedro ;
Zeller, Cordula ;
Schnee, Janet ;
Brueckmann, Martina ;
Pocock, Stuart J. ;
Zannad, Faiez ;
Anker, Stefan D. .
EUROPEAN HEART JOURNAL, 2022, 43 (05) :416-426
123456789